Interim Trials Show Safety of Sputnik Light and AstraZeneca Vaccine Mix

The interim results of the phase II clinical trials held to evaluate the safety and immunogenicity of the combined use of the AstraZeneca vaccine and the first component of the Sputnik V coronavirus vaccine (Sputnik Lite) did not reveal any serious adverse events, the RDIF, AstraZeneca, and R-Pharm said.